Found: 5
Select item for more details and to access through your institution.
Tissue damage and immunity in cutaneous leishmaniasis.
- Published in:
- Parasite Immunology, 2012, v. 34, n. 12, p. 551, doi. 10.1111/pim.12007
- By:
- Publication type:
- Article
Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.
- Published in:
- Clinical & Experimental Immunology, 2002, v. 130, n. 2, p. 307, doi. 10.1046/j.1365-2249.2002.01976.x
- By:
- Publication type:
- Article
Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.
- Published in:
- Clinical & Experimental Immunology, 2008, v. 153, n. 2, p. 221, doi. 10.1111/j.1365-2249.2008.03687.x
- By:
- Publication type:
- Article
Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter STEPIn study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 11, p. 1930, doi. 10.1111/jdv.14979
- By:
- Publication type:
- Article
Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin.
- Published in:
- Clinical & Experimental Allergy, 2014, v. 44, n. 8, p. 1033, doi. 10.1111/cea.12353
- By:
- Publication type:
- Article